Povetacicept
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Povetacicept, covering 2025-07-04 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) [Phase 2, Phase 3]